
Odaberite svoju etiketu
prikazano izravno na bočiciLaboratorijsko izvješće
PDF- Testirano
- BPC + TB Blend 10mg (5+5)
- Laboratorij
- Analiza Białek
- Datum
- October 2026
- Rezultat
- 99% purity (BPC-157 5.47 mg + TB-500 5.29 mg)
- Endotoksini
- 6.00 EU/vial
- Br. narudžbe
- Lozinka
Neovisno testirano, može se provjeriti lozinkom izravno u laboratoriju.
BPC + TB Blend
Healing
- Laboratorijski testirano · Čistoća 99%
- Šalje se iz Njemačke
Narudžba
- DHL s praćenjem
- Diskretno pakiranje
Na prvi pogled
BPC + TB Blend u brojkama
Ključni podaci iz našeg leksikona.
Cijeli članak u leksikonu- Class
- Healing blendBPC-157 + TB-500
- Use
- Subcutaneousin mg, half/half
- Sizes
- 10 to 30 mg3 sizes in the shop
What studies show
The source in the lexicon- Crockford et al., Annals of the New York Academy of Sciences, 2010
Znanje
Sve o BPC + TB Blend
Detaljne informacije uskoro.
Doziranje
Učitavanje podataka o doziranju …
Dobro je imati
Što vam uz to treba
Bakteriostatska voda automatski se dodaje u košaricu. Štrcaljke i maramice jednim klikom.
Inzulinske štrcaljke
10 kom. · 5.50 €
Alkoholne maramice
50 kom. · 10 €
Koliko vode?
Jedinice na štrcaljki za veličinu vaše bočice.
Otvori kalkulator →Are there studies on the ready-made blend?
No. As of 26 October 2026 there is no trial with BPC-157 and TB-500 together on ClinicalTrials.gov. PubMed has one rat study on the Achilles tendon and three case reports on jaw nerve damage in which several peptides and other agents were given together. Cause and effect cannot be derived from them.
Do both work better together?
That is not established. In 32 rats with a repaired Achilles tendon each on its own was linked to better tendon tissue, significantly above all with TB-500, which also raised tensile strength. The combination gave no advantage over either alone. The authors suspect that both feed into the same signalling pathways.
What is TB-500?
TB-500 is sold as a fragment of thymosin beta-4. Thymosin beta-4 is the main peptide that binds free actin in cells and is linked to cell migration, new vessel formation and tissue repair. A 2026 review finds hardly any solid human safety data for TB-500.
How are the two components thought to work?
BPC-157 raised the receptor VEGFR2 and new vessel formation in vessel cells. Thymosin beta-4 carries its vessel-forming effect in its actin-binding motif and sped up wound healing in rats. Both come from cell and animal experiments.
Which trials exist on the components?
Thymosin beta-4 was given into a vein in phase 2 after heart attack and tested earlier as a gel for pressure and leg ulcers, a third heart trial has been announced. For BPC-157 a phase 1 trial after shoulder surgery is planned, a study with gummies was completed without results.
Which side effects are known?
None for the blend. No treatment-related side effects occurred in the three small human studies on BPC-157, but the certainty is very low. 40 healthy people tolerated thymosin beta-4 into a vein without serious side effects. One review warns of risks from unregulated manufacturing.
Povezano
Srodni proizvodi
BPC-157
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
4 veličine
Laboratorijski testirano
= od 5.2 €/bočica
TB-500 (Thymosin B4)
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
3 veličine
Laboratorijski testirano
= od 18.8 €/bočica
TB-500 FRAG
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
1 veličina
= 24.8 €/bočica
BPC + TB + KPV Blend
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
1 veličina
= 52 €/bočica
BPC + TB Blend